1. Home
  2. BFRI vs YOSH Comparison

BFRI vs YOSH Comparison

Compare BFRI & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • YOSH
  • Stock Information
  • Founded
  • BFRI 1997
  • YOSH 2016
  • Country
  • BFRI United States
  • YOSH United States
  • Employees
  • BFRI N/A
  • YOSH N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • BFRI Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • BFRI Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • BFRI 6.2M
  • YOSH 5.6M
  • IPO Year
  • BFRI 2021
  • YOSH 2022
  • Fundamental
  • Price
  • BFRI $0.98
  • YOSH $3.25
  • Analyst Decision
  • BFRI Strong Buy
  • YOSH
  • Analyst Count
  • BFRI 1
  • YOSH 0
  • Target Price
  • BFRI $7.00
  • YOSH N/A
  • AVG Volume (30 Days)
  • BFRI 990.2K
  • YOSH 33.2K
  • Earning Date
  • BFRI 11-13-2024
  • YOSH 11-19-2024
  • Dividend Yield
  • BFRI N/A
  • YOSH N/A
  • EPS Growth
  • BFRI N/A
  • YOSH N/A
  • EPS
  • BFRI N/A
  • YOSH N/A
  • Revenue
  • BFRI $35,358,000.00
  • YOSH $11,652,880.00
  • Revenue This Year
  • BFRI $17.69
  • YOSH N/A
  • Revenue Next Year
  • BFRI $19.71
  • YOSH N/A
  • P/E Ratio
  • BFRI N/A
  • YOSH N/A
  • Revenue Growth
  • BFRI 5.17
  • YOSH 25.97
  • 52 Week Low
  • BFRI $0.61
  • YOSH $2.73
  • 52 Week High
  • BFRI $3.90
  • YOSH $8.46
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 52.63
  • YOSH 42.66
  • Support Level
  • BFRI $0.94
  • YOSH $3.27
  • Resistance Level
  • BFRI $1.06
  • YOSH $3.96
  • Average True Range (ATR)
  • BFRI 0.12
  • YOSH 0.27
  • MACD
  • BFRI -0.01
  • YOSH 0.01
  • Stochastic Oscillator
  • BFRI 28.89
  • YOSH 12.90

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: